mardi 5 décembre 2017

Onco Actu du 5 décembre 2017

1. Biologie

Immune cells share their insides with tumors to promote cancer spread [Fred Hutch]

2.7 Etiologie - Obésité

Take a Number: Two Hidden Cancer Causes: Diabetes and Obesity [NY Times]

4.10 Dép., diag. & prono. - FDA, EMA, NICE,...

Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA ushering in new era of 3D printing of medical products; provides guidance to manufacturers of medical devices [FDA]

5.1 Traitements - Pré-clinique

Fat Cells May Hinder Effectiveness of Chemotherapy [NCI]

5.12.2 Immunothérapies - CAR-T

CRISPR/Cas9 pioneer Chad Cowan enlists in Mustang Bio’s CAR-T quest [EndPoints]

5.3.4 Traitements - AMM (FDA, EMA)

Mylan's Ogivri becomes first and only FDA-approved Herceptin biosimilar [Pharmafile]


SABCS Marks 40 Years [Cancer Research Catalyst]

5.9 AACR

Loxo, Bayer maintain 90%-plus response rate in cancer trial [FierceBiotech]

Updated larotrectinib pediatric clinical trial data demonstrate continued durability of response in TRK fusion cancers [Bayer]

6. Lutte contre les cancers

NHS cancer experts recruited in their hundreds to speed up diagnosis [The Telegraph]

6.5 Médecines alternatives

Integrating pseudoscience and mysticism into oncology in bastions of evidence-based medicine [Respectful Insolence]

6.6 Publications

Federal Trade Commission and National Institutes of Health Take Action Against Predatory Publishing Practices [The Scholarly Kitchen]

6.7.1 Bioinformatique

Tapping the genome's social network to find cancer drivers [Broad Institute]

Google Has Released an AI Tool That Makes Sense of Your Genome [MIT Technology Review]

6.9 Controverses

Investors see big money in infertility. And they’re transforming the industry [STAT]